Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 NULL
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: NULL
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 0

Regulatory News

Manufacturing Scale Up of Lead Ox-1 Programme 17-Jul-2025 07:00 RNS
Result of AGM 09-Jul-2025 15:07 RNS
AGM Statement 09-Jul-2025 07:00 RNS
Notice of AGM 16-Jun-2025 16:10 RNS
Change of Adviser 13-Jun-2025 07:00 RNS
Final results for year to 31 March 2025 03-Jun-2025 07:00 RNS
Notice of Results and Ox-1 presentation 23-May-2025 07:14 RNS
Holding(s) in Company 22-May-2025 12:43 RNS
Director/PDMR Shareholding 22-May-2025 12:22 RNS
Holding(s) in Company 16-May-2025 13:00 RNS
Master Service Agreement signed for Ox-1 programme 12-May-2025 07:00 RNS
Board Appointment, Grant of Options, PDMR Dealing 01-May-2025 07:00 RNS
Holding(s) in Company 21-Mar-2025 15:55 RNS
Holding(s) in Company 20-Mar-2025 15:33 RNS
Holding(s) in Company 20-Mar-2025 11:01 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 0.000p
% Change 0.00 %
52 Week High NULL
52 Week Low 0.000p
Volume 0
Shares Issued 2,148.96m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.95% above the market average5.95% above the market average5.95% above the market average5.95% above the market average5.95% above the market average
85.37% above the sector average85.37% above the sector average85.37% above the sector average85.37% above the sector average85.37% above the sector average
Price Trend
97.44% below the market average97.44% below the market average97.44% below the market average97.44% below the market average97.44% below the market average
95.56% below the sector average95.56% below the sector average95.56% below the sector average95.56% below the sector average95.56% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page